Key Takeaways From Dentsply Sirona Analyst Ratings
Portfolio Pulse from Benzinga Insights
Dentsply Sirona (NASDAQ:XRAY) has been evaluated by 10 analysts over the last three months, showing a mix of bullish to bearish sentiments. Recent adjustments in analyst ratings and price targets reflect a cautious outlook, with a downward trend in the 12-month price targets, now averaging $37.00, a decrease from the previous $38.29. The company, a leading manufacturer of dental equipment and supplies, faces challenges with a -2.56% decline in revenue growth and a market capitalization that remains above industry benchmarks. Despite this, Dentsply Sirona maintains strong financial health indicators such as net margin, ROE, and ROA.
May 06, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Dentsply Sirona has seen a mix of analyst sentiments, with recent adjustments pointing to a cautious outlook. The average price target has been lowered to $37.00, reflecting a 3.37% decrease. Despite a revenue decline, the company's financial health remains strong, with notable performance in net margin, ROE, and ROA.
The mixed analyst ratings and the downward adjustment in price targets suggest a cautious but not overtly negative outlook for Dentsply Sirona. The company's strong financial health indicators, such as net margin, ROE, and ROA, despite a revenue decline, suggest resilience. This analysis leads to a neutral short-term price direction score, reflecting uncertainty in how the market will react to these mixed signals.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100